GlassScriptPhysician profile
Jason J Willis
NPI 1205091410
$5,082.04
in general payments reported to CMS, 2019-2025
41 companies · $535 in 2025
The $535 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,055 · 2020: $238 · 2021: $814 · 2022: $860 · 2023: $802 · 2024: $778 · 2025: $535.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,115.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,114.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $1,323.45 | 2019-2025 | Grafix Pl, Collagenase Santyl, Renasys Touch |
| Stryker Corporation | $717.52 | 2019-2025 | Prostep, Valor, Variax |
| Paragon 28, INC. | $411.50 | 2019 | |
| Abbvie INC. | $326.01 | 2022-2025 | Dalvance |
| Melinta Therapeutics, LLC | $304.61 | 2019-2022 | |
| Depuy Synthes Sales INC. | $265.45 | 2022-2025 | Motoband, Na |
| Reapplix INC. | $195.03 | 2021-2024 | 3c Patch Kit - Box |
| Paratek Pharmaceuticals, INC. | $155.30 | 2021-2024 | Nuzyra |
| Organogenesis INC. | $130.60 | 2022-2024 | Puraply, Apligraf |
| Merck Sharp & Dohme LLC | $118.06 | 2019 | |
| Anika Therapeutics, INC. | $110.08 | 2021 | |
| Wright Medical Technology, INC. | $97.26 | 2019 | |
| Medinc of Texas | $91.90 | 2023-2025 | |
| Treace Medical Concepts, INC. | $90.75 | 2022-2025 | |
| Kci USA, INC. | $65.86 | 2021-2023 | V.A.C. Dermatac, V.A.C. Veraflo Cleanse Choice |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $59.25 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $51.74 | 2025 | |
| Musculoskeletal Transplant Foundation INC. | $50.52 | 2021 | |
| Solventum Corporation | $42.06 | 2024-2025 | V.A.C.Ulta, Activ.A.C. |
| Ibsa Pharma INC. | $41.63 | 2023-2024 | Tirosint, Licart, Tirosint |
| Medtronic, INC. | $38.35 | 2022-2025 | Inceptiv |
| Kerecis Limited | $35.10 | 2023-2025 | Kerecis Omega3 Surgiclose, Kerecis Surgiclose, Kerecis Omega3 Graftguide |
| Sanara Medtech INC. | $30.65 | 2023 | Celleraterx |
| Bioventus LLC | $29.96 | 2023-2024 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Novartis Pharmaceuticals Corporation | $28.31 | 2024 | |
| Mimedx Group, INC. | $24.52 | 2025 | |
| Cardiovascular Systems INC. | $21.14 | 2022 | |
| Janssen Pharmaceuticals, INC | $18.90 | 2022 | |
| Ovik Health, LLC | $18.71 | 2024 | Coflex Tlc |
| Nevro Corp. | $18.50 | 2022 | |
| Osteoremedies, LLC | $18.35 | 2025 | Osteoboost Select 5cc |
| Aroa Biosurgery Incorporated | $17.99 | 2020 | |
| Acera Surgical, INC. | $17.64 | 2023 | Restrata Wound Matrix |
| Grt US Holding, INC. | $17.11 | 2022 | |
| Arthrosurface Incorporated | $17.09 | 2019 | |
| Zimmer Biomet Holdings, INC. | $17.08 | 2019 | |
| Convatec INC. | $15.41 | 2024 | |
| Nabriva Therapeutics, Plc | $13.35 | 2021 | |
| Horizon Therapeutics Plc | $12.99 | 2019 | |
| Medela LLC | $11.44 | 2021 | |
| 3m Company | $10.87 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Willis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.